Title page
Contents
Summary 4
01. Introduction 5
02. Global solidarity and multilateral support 10
Solidarity and leadership on the global stage 11
Solidarity with WHO 13
Access to critical resources 18
Solidarity in science 19
Pharmaceutical companies and solidarity 22
Intellectual property: absence of solidarity 24
03. Case study 1: COVAX, vaccines and solidarity 27
04. Regional solidarity 32
Latin America and the Caribbean 33
Africa 34
Asia-Pacific 35
05. Case study 2: Europe's turbulent journey through solidarity 36
06. Solidarity within countries 40
Solidarity and politics 41
The relationship between policymakers and public health leaders 42
Population buy-in with the national response 44
07. Lessons for solidarity 49
Solidarity between countries 50
Solidarity within countries 52
Acronyms and abbreviations 55
About the authors 56
Acknowledgments 58
Table 1. Distribution of interviewees by organizational affiliation, coding assigned to stakeholder groups in the research, and WHO regional classification 9
Table 2. Top 12 contributions to COVAX AMC (as of 23 June 2021) 16
Figure 1. Timeline of key high-level statements and commitments to solidarity, January 2020-June 2021 14
Figure 2. Confirmed number of doses procured by country income-level classification (as of 9 July 2021) 22